FMP
VolitionRx Limited
VNRX
AMEX
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
0.5 USD
-0.0324 (-6.48%)
About
ceo
Mr. Cameron Reynolds MBA
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://www.volition.comexchange
AMEX
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
CIK
0000093314
ISIN
US9286611077
CUSIP
928661107
Address
13215 Bee Cave Parkway
Phone
646 650 1351
Country
US
Employee
96
IPO Date
Mar 2, 2012
Key Executives
Name
Title
Pay
Year Born
Mr. Nicholas Plummer
Group General Counsel
0
1971
Dr. Jacob Vincent Micallef MBA, Ph.D.
Chief Scientific Officer
571.55k
1956
Dr. Gaetan Michel Ph.D.
Chief Operating Officer
518.15k
1973
Dr. Salvatore Thomas Butera DVM
Chief Executive Officer of Volition Vete...
477.25k
1951
Mr. Terig Hughes
Chief Financial Officer & Treasurer
338.74k
1970
Ms. Louise Batchelor Day
Group Chief Marketing & Communications O...
0
1971
Mr. Gael Forterre M.B.A.
Chief Commercial Officer
0
1981
Mr. Cameron Reynolds MBA
Founder, Chief Executive Officer, Presid...
572.43k
1971
Dr. Andrew Retter MBBS
Chief Medical Officer
0
N/A
Ms. Sharon Ballesteros
U.S. Head of Quality & Development Proce...
0
N/A
As of December 31, 2024, the total employee count stands at 96, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.
